| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300274A Polyenepolycarboxylic acids, derivatives thereof with respect to carboxyl groups, or salts of these |
| 06/20/2001 | CN1300215A Preventives/remedies for skin diseases |
| 06/20/2001 | CN1299821A Lactone compound and its synthesis and use |
| 06/20/2001 | CN1299817A Optically active beta-halo-gamma-crotonic lactone and its synthesis process |
| 06/20/2001 | CN1299816A Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process |
| 06/19/2001 | US6248906 Sequence of three steps |
| 06/19/2001 | US6248905 Oil-solubility; easily permeate into living tissues to release l-ascorbic acid, resulting in an exertion of the physiological action inherent to l-ascorbic acid. |
| 06/19/2001 | US6248866 Multistep process for production of protected hypusine starting from protected, esterified lysine |
| 06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/19/2001 | US6248773 Vision defects |
| 06/19/2001 | US6248764 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 06/19/2001 | US6248737 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects |
| 06/15/2001 | CA2328342A1 Photosensitive resin composition |
| 06/14/2001 | WO2001042408A2 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
| 06/14/2001 | WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 06/14/2001 | WO2001042199A1 Amidinophenylpyruvic acid derivative |
| 06/14/2001 | WO2001041924A2 Oxidative reactions using membranes that selectively conduct oxygen |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
| 06/14/2001 | CA2391984A1 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/13/2001 | EP1106177A1 Tumor tissue accumulation enhancers for drugs |
| 06/13/2001 | EP1106175A1 Anti-inflammatory analgesics |
| 06/13/2001 | EP1105730A1 Enzyme inhibition immunoassay |
| 06/13/2001 | EP1105382A2 Method for the preparation of citalopram |
| 06/13/2001 | EP1105381A1 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
| 06/13/2001 | EP1105373A1 Unsaturated oxime derivatives and the use thereof as latent acids |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105120A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 06/13/2001 | EP0863132B1 Ketonitrile derivatives and antibacterial agent and drug containing the same |
| 06/13/2001 | EP0687174B1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
| 06/13/2001 | DE19959873A1 Oxidationsreaktionen unter Verwendung von gemischtleitenden sauerstoffselektiven Membranen Oxidation reactions using oxygen-selective mixed conducting membranes |
| 06/13/2001 | CN1299365A Hygromycin A derivatives |
| 06/13/2001 | CN1299360A Pesticidal methoximinomethyloxathiazines |
| 06/13/2001 | CN1298877A Tacca chantrieri andre ketonic internal ester and its use |
| 06/13/2001 | CN1298759A Catalyst for preparing gamma-butyrolactone from cis-aldehyde by ordinary-pressure gas-phase hydrogenation and its use |
| 06/13/2001 | CN1067063C Substituted carboxylic acylaniline derivative and plant disease control agent contg. same as active component |
| 06/13/2001 | CN1067050C Method for prodn. of 3-alkoxy-2-substituted phenmethyl acid or ester thereof |
| 06/12/2001 | US6245948 Preparation of tetrahydrofuran from dialkoxybutenes |
| 06/12/2001 | US6245945 Selective hydrolysis of acetals or ketals in the presence of phthalides |
| 06/12/2001 | US6245804 Contraceptives; urogenital disorders |
| 06/12/2001 | US6245449 Material for organoelectroluminescence device and use thereof |
| 06/12/2001 | CA2003388C Neuroprotective pharmaceutical compositions containing arylcyclohexylamines |
| 06/07/2001 | WO2001040256A1 Taccalonolides and their use |
| 06/07/2001 | WO2001040219A2 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
| 06/07/2001 | WO2001040191A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/07/2001 | WO2001040153A1 PROCESS FOR PREPARING OPTICALLY ACTIVE α-HYDROXY ACIDS AND DERIVATIVES THEREOF |
| 06/07/2001 | DE19958496A1 Verfahren zur Herstellung von 5-(1-Piperazinyl)-benzofuran-2-carboxamid durch Übergangsmetallkatalysierte Aminierung A process for the preparation of 5- (1-piperazinyl) benzofuran-2-carboxamide by transition metal amination |
| 06/07/2001 | CA2393012A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/07/2001 | CA2390815A1 Process for preparing optically active .alpha.-hydroxy acids and derivatives thereof |
| 06/06/2001 | EP1104423A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 06/06/2001 | EP1104395A1 Stereoselective ring opening reactions |
| 06/06/2001 | EP0863889B1 Process for hydrogenating dihydrofuranes to tetrahydrofuranes |
| 06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
| 06/06/2001 | CN1298386A N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
| 06/06/2001 | CN1298381A Method for producing 1,4-butanediol |
| 06/06/2001 | CN1066702C Process for producing 1,4-butanediol |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
| 06/05/2001 | US6242493 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/05/2001 | US6242483 Selectively cytotoxic acetogenin compounds |
| 06/05/2001 | US6242480 Ophthalmic viscoelastic compositions |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | CA2048192C Preparation of potassium magnesium l-ascorbate 2-phosphate |
| 05/31/2001 | WO2001038322A1 Inhibitors of histone deacetylase |
| 05/31/2001 | WO2001038316A2 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands |
| 05/31/2001 | WO2001038293A1 Ethers of o-desmethyl venlafaxine |
| 05/31/2001 | WO2001038280A1 Method for oxidation of xylene derivatives |
| 05/31/2001 | WO2001038276A1 Process for the production of alkanediol derivatives |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | US20010002400 Administering an antifungal agent |
| 05/31/2001 | DE19956791A1 New 2-heterocyclyl-4-arylsulfonyl-5-amino-oxazole derivatives useful in treatment of central nervous system disorders and as pesticides |
| 05/31/2001 | CA2391288A1 Ethers of o-desmethyl venlafaxine |
| 05/31/2001 | CA2389679A1 Novel sulfonyloxazolamines |
| 05/30/2001 | EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof |
| 05/30/2001 | EP1102761A2 Cyclopentabenzofuran derivatives and their use |
| 05/30/2001 | EP1102760A1 Process for the oxidation of butadiene and butene with cobalt and molybdenum oxide based catalysts |
| 05/30/2001 | EP1102759A1 Methods for synthesis of substituted tetrahydrofuran compound |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | EP0914334B1 Process and intermediates for the synthesis of lhrh antagonists |
| 05/30/2001 | CN1297446A Preparation of cis-6,6-dimethyl-3-oxa-bicyclo (3.1.0) hexan-2-one |
| 05/30/2001 | CN1066432C Process for preparation of citraconic anhydride |
| 05/30/2001 | CN1066336C Pharmaceutical composition for treatment of alcohol addiction |
| 05/29/2001 | US6239311 Process for the preparation of 3,4-dihydroxybutanoic acid and salts and lactones derived therefrom |
| 05/29/2001 | US6239295 Process for producing 3-methyltetrahydrofuran, and process for producing an intermediate thereof |
| 05/29/2001 | US6239292 Process for preparing gamma-butyrolactone, butane-1,4-diol and tetrahydrofuran |
| 05/29/2001 | US6239289 O-(perfluoroalkyl)dibenzofuranium salt derivatives, intermediates for the preparation of the same, process for the preparation of the intermediates, perfluoroalkylating agents, and process for perfluoroalkylation |
| 05/29/2001 | US6239284 Skin disorders; anticancer agents |
| 05/29/2001 | US6239237 Group 8, 9 or 10 transition metal catalyst for olefin polymerization |
| 05/29/2001 | US6239176 Administering to treat blood disorders like anemia; wound healing, anticarcinogenic and antiproliferative agents; genetic disorders |
| 05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |